Neovision Capital Investor
Neovision Capital is an investment firm dedicated to both early and growth-stage investment in Chinese healthcare and TMT sectors.
Technology:
NeuroTech
Industry:
Financial Services, Lending and Investments, Professional Services
Headquarters:
Shanghai, Shanghai, China
Founded Date:
1/1/2015
Funding Status:
Private
Investor Type:
Venture Capital
Investment Stage:
Early Stage Venture, Late Stage Venture
Number Of Exits:
1
Investors Number:
28
Register and Claim Ownership